Literature DB >> 8467273

Subjective craving for opiates: evaluation of a cue exposure protocol for use with detoxified opiate addicts.

J Powell1, J Gray, B Bradley.   

Abstract

Cue exposure has been advocated as an intervention for reducing relapse rates in detoxified addicts, by extinguishing classically conditioned drug effects/craving which may have developed. Several studies with alcoholics have found cue exposure to be associated with reductions in craving, but no controlled study has yet shown such an effect in opiate addicts. The present controlled group design evaluates a protocol which draws from experience in the treatment of anxiety and requires that each stimulus exposure should be continued until within-session habituation has occurred. It also explores whether there is any benefit of using a 'cognitive aversion' strategy during cue exposure, based on the social learning analysis that craving derives from expectancies of positive drug effects. A total of 21 detoxified in-patients were randomized to routine ward treatment plus two sessions of either cue exposure (Group E) or cue exposure and cognitive aversion (Group E/CA), or to routine treatment alone (Group C). A specially designed Craving Test was carried out before and after treatment, to assess change in cue-elicited reactions. The two treated groups showed significantly greater reductions in craving than Group C, but did not differ from each other. The cue exposure protocol has therefore been adopted for use in an ongoing clinical trial.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8467273     DOI: 10.1111/j.2044-8260.1993.tb01026.x

Source DB:  PubMed          Journal:  Br J Clin Psychol        ISSN: 0144-6657


  13 in total

1.  Extinction of drug- and withdrawal-paired cues in animal models: relevance to the treatment of addiction.

Authors:  Karyn M Myers; William A Carlezon
Journal:  Neurosci Biobehav Rev       Date:  2010-01-28       Impact factor: 8.989

2.  Initial RCT of a distress tolerance treatment for individuals with substance use disorders.

Authors:  Marina A Bornovalova; Kim L Gratz; Stacey B Daughters; Elizabeth D Hunt; C W Lejuez
Journal:  Drug Alcohol Depend       Date:  2011-10-07       Impact factor: 4.492

Review 3.  Role of cues and contexts on drug-seeking behaviour.

Authors:  Christina J Perry; Isabel Zbukvic; Jee Hyun Kim; Andrew J Lawrence
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

Review 4.  A review of the effects of perceived drug use opportunity of self-reported urge.

Authors:  J M Wertz; M A Sayette
Journal:  Exp Clin Psychopharmacol       Date:  2001-02       Impact factor: 3.157

5.  Cue-induced craving and physiological reactions in recently and long-abstinent heroin-dependent patients.

Authors:  Min Zhao; Chenglu Fan; Jiang Du; Haifeng Jiang; Hanhui Chen; Haiming Sun
Journal:  Addict Behav       Date:  2011-11-29       Impact factor: 3.913

6.  Acute and repeated exposure to caffeine: effects on reinstatement of extinguished cocaine-taking behavior in rats.

Authors:  S Schenk; C M Worley; C McNamara; A Valadez
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

7.  The effects of varied extinction procedures on contingent cue-induced reinstatement in Sprague-Dawley rats.

Authors:  Deanne M Buffalari; Matthew W Feltenstein; Ronald E See
Journal:  Psychopharmacology (Berl)       Date:  2013-06-18       Impact factor: 4.530

Review 8.  The strength of aversive and appetitive associations and maladaptive behaviors.

Authors:  Yossef Itzhak; Daniel Perez-Lanza; Shervin Liddie
Journal:  IUBMB Life       Date:  2014-09-05       Impact factor: 3.885

9.  Cue-induced craving in dependence upon prescription opioids and heroin.

Authors:  R Kathryn McHugh; Sara Park; Roger D Weiss
Journal:  Am J Addict       Date:  2014-03-15

10.  Attending to emotional cues for drug abuse: bridging the gap between clinic and home behaviors.

Authors:  Michael W Otto; Conall M O' Cleirigh; Mark H Pollack
Journal:  Sci Pract Perspect       Date:  2007-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.